Rus Tourism News
LOT

LOT Cargo Develops Offer in Transport of PIL

LOT Polish Airlines and SkyCell signed an agreement that extends LOT Cargo’s capabilities in the transport of medicines and pharmaceutical products (PIL). Thanks to advanced technology, SkyCell’s hybrid containers guarantee to maintain a constant transport temperature necessary for transporting demanding shipments even to distant regions of the world.

The transport of pharmaceutical products requires the airlines to apply specialist solutions and meet demanding standards guaranteeing safety and the highest quality of provided services. Pharma and Life-Science is a critical sector of global cargo transport for LOT; therefore, the company is constantly increasing its competencies and improving its offer addressed to companies operating in this industry. In July 2020, LOT Cargo obtained the IATA CEIV Pharma certificate, which gave the Polish carrier a place in the prestigious group of 25 airlines with a documented and approved PIL QMS Quality Management System for pharmaceutical shipment management.

The agreement signed with SkyCell is the next step distinguishing LOT Cargo’s offer on the market. Modern hybrid containers allow for securing temperatures between +15°C/+25°C, +2°C/+8°C, -30°C/-15°C and -60°C/-80°C, required among others
for transporting vaccines. Hybrid containers:

Are an essential element of an integrated, cold supply chain,
Allow the maintenance of stable parameters of transporting medicines or pharmaceuticals even over long distances,
Thereby ensure the security of the whole process of delivery from the manufacturer to the recipient.

LOT Cargo transports medicines and pharmaceutical goods in the Boeing 787 Dreamliner. The front cargo compartment
is equipped with a temperature control system, which effectively combines two essential elements of transporting PIL shipments – temperature control by installation onboard the aircraft as well as through a container.

Hybrid containers offered by SkyCell are one of the most modern solutions in this area, used in transport by leading pharma companies and the largest airlines in the world. The Swiss company has developed a technology that reduces risks with
an audited performance of less than 0.1% temperature excursions during the transport of sensitive products.

Iuliia Tore